Accelerate Diagnostics, Inc. (AXDX) Analysts See $-0.31 EPS; 5 Bullish Analysts Covering Jones Energy, Inc. (JONE)

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Logo

Analysts expect Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report $-0.31 EPS on May, 4.They anticipate $0.04 EPS change or 14.81% from last quarter’s $-0.27 EPS. After having $-0.27 EPS previously, Accelerate Diagnostics, Inc.’s analysts see 14.81% EPS growth. The stock decreased 0.86% or $0.2 during the last trading session, reaching $23.05. About 115,440 shares traded. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 0.88% since April 29, 2017 and is downtrending. It has underperformed by 12.43% the S&P500.

Among 14 analysts covering Jones Energy Inc (NYSE:JONE), 5 have Buy rating, 3 Sell and 6 Hold. Therefore 36% are positive. Jones Energy Inc has $9.75 highest and $0.5 lowest target. $4.82’s average target is 627.66% above currents $0.6624 stock price. Jones Energy Inc had 35 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Jones Energy, Inc. (NYSE:JONE) has “In-Line” rating given on Wednesday, March 9 by Imperial Capital. The stock has “Outperform” rating by Imperial Capital on Monday, August 22. IBERIA Capital upgraded Jones Energy, Inc. (NYSE:JONE) on Tuesday, May 24 to “Outperform” rating. Stifel Nicolaus upgraded it to “Buy” rating and $6.0 target in Wednesday, October 5 report. On Tuesday, March 13 the stock rating was maintained by Stephens with “Hold”. As per Tuesday, January 17, the company rating was upgraded by Suntrust Robinson. Seaport Global initiated the stock with “Accumulate” rating in Tuesday, August 30 report. As per Friday, December 15, the company rating was downgraded by JP Morgan. J.P. Morgan downgraded the stock to “Hold” rating in Thursday, July 20 report. On Friday, December 15 the stock rating was downgraded by J.P. Morgan to “Sell”. See Jones Energy, Inc. (NYSE:JONE) latest ratings:

13/03/2018 Broker: Stephens Rating: Hold New Target: $1.0 Maintain
02/01/2018 Broker: SunTrust Old Rating: Buy New Rating: Hold Downgrade
02/01/2018 Broker: Suntrust Robinson Old Rating: Buy New Rating: Hold Downgrade
15/12/2017 Broker: J.P. Morgan Rating: Sell Downgrade
15/12/2017 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Downgrade
20/11/2017 Broker: Barclays Capital Rating: Underweight Old Target: $1.5 New Target: $0.5 Maintain
09/11/2017 Broker: Noble Financial Rating: Hold Maintain
08/11/2017 Broker: Stephens Old Rating: Overweight New Rating: Equal-Weight Downgrade

Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 9 analyst reports since August 25, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray on Sunday, September 17 with “Buy”. On Wednesday, December 16 the stock rating was initiated by Piper Jaffray with “Overweight”. As per Wednesday, July 12, the company rating was reinitiated by BTIG Research. The stock has “Buy” rating by Piper Jaffray on Thursday, August 3. BTIG Research downgraded Accelerate Diagnostics, Inc. (NASDAQ:AXDX) on Wednesday, December 13 to “Neutral” rating. The company was initiated on Thursday, March 24 by JP Morgan. As per Tuesday, August 9, the company rating was maintained by JP Morgan. BTIG Research upgraded the shares of AXDX in report on Tuesday, August 25 to “Neutral” rating. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Outperform” rating by William Blair on Friday, January 8.

Investors sentiment decreased to 0.81 in 2017 Q4. Its down 0.82, from 1.63 in 2017Q3. It dived, as 21 investors sold Accelerate Diagnostics, Inc. shares while 32 reduced holdings. 15 funds opened positions while 28 raised stakes. 19.90 million shares or 6.66% less from 21.32 million shares in 2017Q3 were reported. Selkirk Mngmt Ltd Liability Company owns 361,550 shares for 5.06% of their portfolio. Birchview Capital L P owns 33.54% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 2.18 million shares. Parametric Portfolio Assocs Limited Liability Company, Washington-based fund reported 30,470 shares. Balyasny Asset Management Limited Liability Co owns 380,465 shares. Vanguard Group Inc holds 1.33 million shares or 0% of its portfolio. Next Century Growth Invsts Ltd Liability has invested 2.15% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Rhumbline Advisers has invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Royal Bancorp Of Canada stated it has 3,168 shares or 0% of all its holdings. Kornitzer Cap Ks has 439,504 shares for 0.2% of their portfolio. Amundi Pioneer Asset Mgmt Incorporated holds 0.01% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 202,690 shares. Voya Ltd Liability Corp holds 0% or 11,589 shares. California Employees Retirement owns 28,800 shares or 0% of their US portfolio. First Republic Investment Mgmt holds 0.11% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 608,600 shares. 9,000 were reported by Barbara Oil Com. Atlantic Tru Group Inc Ltd, Georgia-based fund reported 46,660 shares.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. The company has market cap of $1.29 billion. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. It currently has negative earnings. The firm was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012.

Since February 20, 2018, it had 5 buys, and 0 sales for $1.50 million activity. The insider SCHULER JACK W bought 10,000 shares worth $251,600.

The stock decreased 0.81% or $0.0054 during the last trading session, reaching $0.6624. About 1.05 million shares traded or 1.94% up from the average. Jones Energy, Inc. (NYSE:JONE) has declined 62.44% since April 29, 2017 and is downtrending. It has underperformed by 73.99% the S&P500.

Jones Energy, Inc., an independent oil and gas company, acquires, explores for, develops, and produces oil and natural gas properties in the mid-continent region of the United States. The company has market cap of $67.34 million. It owns leasehold interests in oil and natural gas producing properties, as well as in undeveloped acreage located in the Anadarko and Arkoma basins in Texas and Oklahoma. It currently has negative earnings. As of December 31, 2015, the companyÂ’s total estimated proved reserves included 105.2 million barrels of oil equivalent.

Investors sentiment increased to 1.41 in 2017 Q4. Its up 0.30, from 1.11 in 2017Q3. It increased, as 17 investors sold Jones Energy, Inc. shares while 12 reduced holdings. 13 funds opened positions while 28 raised stakes. 58.00 million shares or 2.73% more from 56.45 million shares in 2017Q3 were reported. Legal & General Gp Public Ltd Co holds 0% in Jones Energy, Inc. (NYSE:JONE) or 13,997 shares. Cubist Systematic Strategies Ltd Llc has invested 0% of its portfolio in Jones Energy, Inc. (NYSE:JONE). Raymond James And Assoc reported 0% of its portfolio in Jones Energy, Inc. (NYSE:JONE). Grp One Trading L P reported 1,047 shares stake. Balyasny Asset Mgmt Limited Liability reported 300,000 shares. Rhumbline Advisers invested in 43,141 shares. Raymond James Financial Svcs Advsrs holds 0% or 629,585 shares. The New York-based Tower Ltd Liability Co (Trc) has invested 0% in Jones Energy, Inc. (NYSE:JONE). Susquehanna Intll Group Incorporated Limited Liability Partnership owns 37,688 shares. Goodman Financial Corporation holds 0.96% or 1.93M shares in its portfolio. Moreover, Magnetar Ltd Liability has 0.01% invested in Jones Energy, Inc. (NYSE:JONE). Northern invested 0% in Jones Energy, Inc. (NYSE:JONE). Dimensional Fund Advsr L P has 0% invested in Jones Energy, Inc. (NYSE:JONE). Schwab Charles Inv Mngmt accumulated 100,000 shares. Blackrock stated it has 3.76 million shares or 0% of all its holdings.

Jones Energy, Inc. (NYSE:JONE) Institutional Positions Chart